Preferential binding of the epidermal growth factor receptor to ganglioside GM3 coated plates
- 67 Downloads
Ganglioside GM3 has been shown to modulate epidermal growth factor receptor function. These observations have lead to the hypothesis that GM3 may bind to the epidermal growth factor receptor. An enzyme-linked immunosorbant assay was designed to test this hypothesis. In these experiments, receptor-rich vesicle preparations were incubated with ganglioside GM1 or GM3 coated 96-well microtiter plates and the amount of bound receptor was compared. Plates coated with GM3 consistently bound more epidermal growth factor receptor than did GM1 coated wells appeared to be specific and saturable. These results suggest that GM3 may modulate epidermal growth factor receptor function owing to a specific association of the two molecules.
Index EntriesGangliosides GM3 epidermal growth factor receptor lipid-protein interactions
Unable to display preview. Download preview PDF.
- Bremer E. G. (1994) Glycosphingolipids as effectors of growth and differentiation, inCell Lipids: from Synthesis to Cell Biology (Hoekstra, D., ed.), Academic, Orlando, FL (in press).Google Scholar
- Fredman P. (1988) Gangliosides in human malignant gliomas, inNew Trends in Ganglioside Research: Neurochemical and Neurogenerative Aspects (Ledeen R. W., Hogan E. L., Tettamanti G., Yates A., and Yu R. K., eds.), pp. 161, 161, Liviana Press, Padova.Google Scholar
- Hermanson M., Funa K., Hartman M., Claesson-Welsh L., Heldin C. H., Westermark B., and Nister M. (1992) Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops.Cancer Res. 52, 3213–3219.PubMedGoogle Scholar
- Humphrey P. A., Wong A. J., Vogelstein B., Zalutsky M. R., Fuller G. N., Archer G. E., Friedman H. S., Kwatra M. M., Bigner S. H., and Bigner D. D. (1990) Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.Proc. Natl. Acad. Sci. USA 87, 4207–4211.CrossRefGoogle Scholar
- Nojiri H., Stroud M., and Hakomori S. (1991) A specific type of ganglioside as a modulator of insulin-dependent cell growth and insulin receptor tyrosine kinase activity: possible association of ganglioside-induced inhibition of insulin receptor function and monocytic differentiation induction of HL-60 cells.J. Biol. Chem. 266, 4531–4537.PubMedGoogle Scholar
- Yates A. J., Van Brocklyn J., Saqr H. E., Guan Z., Stokes B. T., and O’Dorisio M. S. (1993) Mechanisms through which gangliosides inhibit PDGF-stimulated mitogenesis in intact Swiss 3T3 cells: receptor tyrosine phosphorylation, intracellular calcium, and receptor binding.Exp. Cell Res. 204, 38–45.CrossRefGoogle Scholar